Advisory Services & Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Advisory Services & Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,485	Closed	-$207K	–	39
2023 Q2	$207K	Buy	+2,485	New	+$208K	0.17%	35

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Advisory Services & Investments's XBI Position: Q3 2023 in Review

Advisory Services & Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 2,485 shares — an estimated $207K sold.

Advisory Services & Investments first reported a position in XBI in Q2 2023 and held it in 1 quarter. The position peaked at $207K in Q2 2023. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Advisory Services & Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Advisory Services & Investments sold 2,485 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $207K.
Advisory Services & Investments first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and held it in 1 quarter.
Advisory Services & Investments's State Street SPDR S&P Biotech ETF position peaked at $207K in Q2 2023.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Advisory Services & Investments's 13F filing for Q3 2023, filed 10 Oct 2023.